Furthermore, hepatitis only occurred in the presence of functional B, T, and NKT cells and treatment with NKG2D neutralizing antibody dramatically reduced IFN-γ and IL-4 expression and liver damage. The gene discussed is KLRK1; the disease is hepatitis A virus infection.